CVS Health Co. (NYSE:CVS) Shares Sold by TrinityPoint Wealth LLC

TrinityPoint Wealth LLC lessened its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 89.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 6,833 shares of the pharmacy operator's stock after selling 59,103 shares during the period. TrinityPoint Wealth LLC's holdings in CVS Health were worth $307,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Stonebridge Financial Group LLC purchased a new position in CVS Health during the fourth quarter valued at approximately $28,000. Hopwood Financial Services Inc. bought a new stake in shares of CVS Health in the fourth quarter worth about $29,000. Financial Perspectives Inc increased its stake in shares of CVS Health by 137.5% during the fourth quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock valued at $36,000 after buying an additional 466 shares during the period. MidAtlantic Capital Management Inc. lifted its position in shares of CVS Health by 112.1% in the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock worth $37,000 after purchasing an additional 437 shares during the period. Finally, Compass Planning Associates Inc bought a new stake in CVS Health during the 4th quarter valued at approximately $37,000. 80.66% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other news, SVP James David Clark sold 7,513 shares of the business's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the sale, the senior vice president now owns 8,394 shares of the company's stock, valued at $556,941.90. The trade was a 47.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.22% of the stock is currently owned by company insiders.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $1.95 during trading on Thursday, hitting $60.16. The stock had a trading volume of 10,041,157 shares, compared to its average volume of 11,364,464. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The stock has a market capitalization of $76.10 billion, a price-to-earnings ratio of 16.44, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. The stock has a 50-day simple moving average of $66.41 and a two-hundred day simple moving average of $59.34.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion for the quarter, compared to the consensus estimate of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.31 earnings per share. On average, equities research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd were issued a $0.665 dividend. The ex-dividend date of this dividend was Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.42%. CVS Health's payout ratio is 63.48%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the stock. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Cowen reaffirmed a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Cantor Fitzgerald raised shares of CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of CVS Health from $80.00 to $81.00 and gave the stock an "overweight" rating in a report on Tuesday, February 18th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $74.94.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.